Home > Insider Trading > Filing (0001567619-21-002796)

Filing Details

Accession Number:: 0001567619-21-002796
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-02-10 16:12:50
Reporting Period:: 2021-02-08

Accepted Time:: 2021-02-10 16:12:50
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1373670	Green Brick Partners Inc.	GRBK	()	DE

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1079114	Greenlight Capital Inc	140 East 45Th Street 24Th Floor New York NY 10017	No	No	Yes	No
1240451	David Einhorn	140 East 45Th Street Floor 24 New York NY 10017	Yes	No	Yes	No
1300763	Dme Advisors, Lp	140 East 45Th Street 24Th Floor New York NY 10017	No	No	Yes	No
1358081	Dme Advisors Gp, L.l.c.	140 East 45Th Street 24Th Floor New York NY 10017	No	No	Yes	No
1489933	Dme Capital Management, Lp	140 East 45Th Street 24Th Floor New York NY 10017	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2021-02-08	393,111	$20.55	8,592,845	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2021-02-08	239,522	$20.55	5,235,633	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2021-02-08	67,367	$20.55	2,740,190	No	4	S	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	8,922	Direct
Common Stock	850,000	Indirect	See Footnote

Footnotes

As previously disclosed, on January 25, 2021, in connection with a registered public secondary offering (the "Secondary Offering") of shares of Common Stock (the "Common Stock") of the Issuer, the Reporting Persons (as defined below) entered into an Underwriting Agreement (the "Underwriting Agreement") with Barclays Capital Inc. and Goldman Sachs & Co. LLC (the "Underwriters") and the Issuer. As also disclosed, the Reporting Persons agreed in the Underwriting Agreement to grant the Underwriters a 30-day option to purchase additional shares of Common Stock at a price of $20.55 per share. On February 8, 2021, the Underwriters notified the Reporting Persons that they were exercising their right to purchase from the Reporting Persons an aggregate of 700,000 shares of Common Stock under such option.
David Einhorn is the president of Greenlight Capital, Inc. ("Greenlight Inc.") and the senior manager of DME Advisors GP, LLC ("DME GP"). DME GP is the general partner of DME Advisors, LP ("DME") and DME Capital Management, LP ("DME CM" and, together with Greenlight Inc., DME GP, DME, and Mr. Einhorn, the "Reporting Persons"). Mr. Einhorn may be deemed to beneficially own the securities reported herein by virtue of his positions with respect to Greenlight Inc. and DME GP.
The Reporting Persons control the disposition and voting of shares of Common Stock held for the account of Greenlight Capital Offshore Partners, Ltd. ("GCOP, Ltd."), Greenlight Capital Offshore Master, Ltd. ("GCOM"), Solasglas Investments, LP ("SILP") and a private investment fund for which DME CM manages a portfolio (the "Sub-Account"), in the respective capacities and quantities further described in the footnotes below. Holdings reported herein reflect a prior reallocation of shares of Common Stock in connection with an internal reorganization that was exempt from reporting under Rule 16a-13, in which there was no change in any Reporting Person's pecuniary interest in the Common Stock.
Pursuant to Rule 16a-1 under the Securities Exchange Act of 1934, as amended (the "Act"), the Reporting Persons disclaim beneficial ownership of the Common Stock except to the extent of their respective pecuniary interests therein. The filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is for the purposes of Section 16(a) of the Act, or otherwise, the beneficial owner of any of the Common Stock held for the account of GCOP, Ltd., GCOM, SILP or the Sub-Account.
Greenlight Inc. controls the voting and disposition of 8,592,845 shares of Common Stock held for the account of GCOP, Ltd. of which Greenlight Inc. acts as investment advisor.
DME CM controls the voting and disposition of 5,235,633 shares of Common Stock held for the account of GCOM, of which DME CM acts as investment advisor.
DME controls the voting and disposition of 2,740,190 shares of Common Stock held for the account of SILP, of which DME serves as investment advisor.
DME CM controls the voting and disposition of 850,000 shares of Common Stock held for the account of the Sub-Account, of which DME serves as an investment advisor.